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Glioblastoma is the most common primary brain tumor with the most dismal prognosis. It is characterized by extensive invasion,
migration, and angiogenesis. Median survival is only 15 months due to this behavior, rendering focal surgical resection ineﬀective
and adequate radiotherapy impossible. At this moment, several ion channels have been implicated in glioblastoma proliferation,
migration, and invasion. This paper summarizes studies on potassium, sodium, chloride, and calcium channels of glioblastoma.
It provides an up-to-date overview of the literature that could ultimately lead to new therapeutic targets.
1.Introduction
Glioblastoma (astrocytomas, WHO grade IV) is the most
aggressive primary brain tumor. With an incidence of 3.5 per
100,000 people per year, it may aﬀect children, adults, and
elderly. However, it preferentially aﬀects adults between 45
and 75 years of age [1].
Glioblastomas can either present themselves as primary
glioblastomas (95%), which manifest de novo and lack pre-
cursor tumors, or secondary glioblastomas. These tumors
have progressed from less malignant glioma [2].
Surgery is the initial intervention when a patient has
been diagnosed with a brain tumor. This is needed to obtain
a histological diagnosis and reduces the space-occupying
eﬀect of the tumor. However, in glioblastoma, surgery is of
limitedtherapeuticvalue,ascompleteresectionisimpossible
due to the extensive invasive, and migratory behavior of
glioblastoma cells. This renders radiotherapy ineﬀective as
well.Thecurrenttreatmentisconcomitantadministrationof
temozolomide and radiotherapy. However, median survival
is only 15 months [3].
The understanding of molecular alterations in signaling
pathways and the consequent pathology in glioblastoma has
greatly increased in the last years due to the availability of
new techniques, such as genome-wide sequencing. One of
the pathways that are frequently aﬀected in glioblastoma
includes channels involved in transport of sodium, potas-
sium, and calcium ions [4]. The present paper provides an
overview of the current evidence of the involvement of these
ion channels in glioblastoma in terms of gliomagenesis,
glioma progression, and their eﬀect on prognosis. Because
of the progression of lower-grade glioma to glioblastoma,
the involvement of ion channels in high-grade glioma is
discussed as well. Finally, the application of these insights
is discussed in the light of future prospects for experimental
and clinical practice.
2. Ion Channelsand Glioblastoma
Glial cells express a variety of ion channels [5]. Recently,
genome-wide analyses of glioblastoma became available. A
survey of the coding sequence of 20,661 genes in glioblas-
toma genomes has implicated many new gene alterations.
One cluster of mutated genes reported was that of ion
channel genes. Of the 555 genes involved in potassium,
sodium, chloride, calcium and other ion transport, 55
mutations were detected to aﬀect 90% of the glioblastoma
samples studied [4].
Ion channels are thought to facilitate progression
through cell cycle checkpoints and thereby are required for
cell proliferation. This process most probably occurs via
modulation of the resting membrane potential. For example,
progression through the G1/S checkpoint is correlated with
increased potassium K+ channel activity and momentary
hyperpolarization [6]. To illustrate this, iberiotoxin, a
pharmacological inhibitor of big conductance K+ channels,2 ISRN Neurology
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Figure 1: gBK channels (a) facilitate an increased outwardly K+ current. Ca2+ input for gBK channels is provided by IP3R (b). ClC-3
channels facilitate an increased Cl￿ outwardly current. (a) and (c) facilitate increased H2O movement through osmosis (d) over the plasma
membrane. Glioblastoma AMPA receptors (e) lack the GluR2 subunit and therefore have increased Ca2+ permeability. Amiloride-sensitive
BNaC channels (f) are expressed in glioblastoma. Kir channels are mislocalized to the cell nucleus (g), diminishing inwardly rectifying K+
currents.
arrests glioma cells in S phase of the cell cycle [7]. On
the other hand, transient depolarization facilitated by Cl−
channels is observed at the G2/M checkpoint [6]. It is for
these reasons that uncontrolled ion channel activity can
contribute to oncogenesis.
Asstatedbefore,theprognosisofglioblastomaisabysmal
due to its invasive migration, which renders surgical resec-
tion ineﬀective. Ion channels may contribute to this invasion
and migration. They inﬂuence shape and volume of cancer
cells by aﬀecting ion and water transport over the plasma
membrane.Ionchannelstherebyfacilitateinvasivemigration
through the sinuous extracellular space of brain tissue [8–
13] (Figure 1). In addition, ion channels may be functionally
involved in proliferation [7, 14, 15]. It is for these reasons
that ion channels may contribute to the malignant behavior
of glioblastoma cells. Therefore, ion channels may be novel
therapeutic targets in the treatment of glioblastoma.
2.1. Potassium Channels
2.1.1. Ca2+-Activated K+ Channels. Ca2+-activated K+ chan-
nels facilitate outwardly rectifying potassium currents and
respondtoCa2+ concentrations.Increasesintheintracellular
[Ca2+] shift the voltage dependence of Ca2+-activated K+
channels to more negative potentials.
One of these channels, big conductance K+ channels or
BK channels, is widely expressed in excitable and non-
excitable cells. BK channels respond to both membrane
voltage potentials and intracellular [Ca2+][ 16].
SpeciﬁcoverexpressionofBKchannelshasbeenobserved
in biopsies of patients with malignant gliomas, compared
with nonmalignant human cortical tissues. In addition,
expression levels correlate positively with the malignancy
grade of the tumor [16]. Lastly, BK currents in glioma cells
a r em o r es e n s i t i v et oi n t r a c e l l u l a r[ C a 2+]c o m p a r e dt oB K
channels in healthy glial cells [17, 18].
BK channels can express a variety of electrophysiological
properties, which is due to alternative splicing of their α-
subunits. The increased sensitivity to intracellular [Ca2+]i s
found in a novel splice isoform of hSlo, the gene that encodes
theα-subunits.ThisBKchannelisoformhasexclusivelybeen
observed to be expressed in glioma. In addition, glioma most
likely only expresses this new isoform, as the classical BK
channelhasnotbeenfoundingliomasyet.Theseﬁndingsled
to the term glioma BK (gBK) channel (Figure 1).
gBK channels have been suggested as a candidate channel
forprovidingtheelectrochemicaldrivingforceforionmove-
ment needed for the release of cytoplasmic water and cell
shrinkage which in turn facilitates the extensive migrating
behavior of glioblastoma cells. First of all, the eﬀect of
menthol was studied, an agonist of transient receptor poten-
tial melastatin 8 (TPRM8) ion channels, which increases
intracellular [Ca2+], which in turn activates gBK channels.
Menthol stimulated glioma cell migration [11, 12]. In addi-
tion, administration of paxilline and tetraethylammonium,
both gBK channel inhibitors, inhibited migration [11, 12].
These ﬁndings make a role of gBK channels in the migration
of glioblastoma cells probable. However, the eﬀect of gBK
channel knockdown has yet to be investigated, leaving room
for doubt.
In contrast to the better studied role that gBK channels
have in glioblastoma cell invasive migration, there is dis-
cussion whether or not gBK channels contribute to prolif-
eration. Some studies have implicated gBK channels in the
proliferation of glioblastoma cells. Glioblastoma cells were
exposed topharmacologicalinhibitors ofgBKchannels,such
asiberiotoxin,paxilline,tetraethylammonium,andpenitrem
A. After 3 to 5 days, growth inhibition and even tumor
shrinkage were observed in vitro [7, 14, 15]. In contrast,
morerecentliteraturecontradictstheseﬁndingsandsuggests
that gBK channels are not required for proliferation or
even have antitumorigenic properties. It has been found
that pharmacological inhibitors suppress glioblastoma cell
growth at concentrations far higher than concentrations
that were suﬃcient to inhibit gBK channel activity. Low
concentrations that were suﬃcient to inhibit these channels
did not aﬀect glioblastoma cell growth in vitro. In addition,ISRN Neurology 3
downregulation of gBK channels using gene-speciﬁc siRNAs
reduced K+ current densities, but caused no changes in pro-
liferation [19]. This argues against a critical role for gBK in
glioblastoma proliferation.
Inositol 1,4,5-triphosphate receptors (IP3Rs) may pro-
vide Ca2+ for gBK channels (Figure 1). These receptors are
localized close to and are linked with gBK channels in
dedicated plasma membrane domains called lipid rafts.
Disruption of these lipid rafts with methyl-β-cyclodextrin
disturbs the connection between gBK channels and Ca2+.
This disturbance was restored by inclusion of Ca2+ in
the pipette solution during the whole cell patch-clamp
experiments. This suggests that the disturbance was not
caused by destruction or calcium desensitization of the gBK
channels [20].
2.1.2. Inwardly Rectifying K+ Channels. Glioma cells both
in vitro and in situ are characterized by depolarized resting
membrane potentials of about −20 to −40mV [21]. In
addition, they express increased outwardly rectifying K+
currents [16]. This contrasts the very negative resting
membrane (−80 to −90mV) and large inwardly rectifying
K+ currents that characterize normal glial cells [22]. These
ﬁndings have led to the assumption that glioma cells express
a decreased density of inwardly rectifying K+ channels (Kir)
compared to normal brain tissue.
However, western blot analysis of D54 glioblastoma cell
lines showed only slightly lowered expression of Kir2.1,
normal expression of Kir4.1, and increased expression
of Kir2.3 and Kir3.1 as compared to normal astrocytes,
while electrophysiological recording found no Kir current.
Immunocytochemistry placed suspicion on mislocalization
of Kir channels in glioblastoma cells. Immunostaining of
Kir2.3 and Kir4.1 predominantly labeled the nucleus of
glioblastoma cells (Figure 1), while expression in normal
astrocytes was diﬀuse over the plasma membrane [23]. The
intracellular localization of Kir channels may explain why
glioblastoma cells express a depolarized resting membrane
potential and decreased inwardly rectifying K+ current.
Kir channels in glial cells are speciﬁcally known for two
functions: buﬀering of extracellular K+ and establishment
of a very negative resting potential [24]. Glial cells perform
K+ uptake from the extracellular space and redistribute K+
ions toward areas where the extracellular [K+]i sl o w e r .
This process includes diﬀusion from cell to cell through
gap junctions. Eventually, K+ is released into blood vessels.
This K+ buﬀering by glial cells is essential for neuronal
homeostasis, as elevated extracellular [K+] would depolarize
neurons, preventing them from ﬁring action potentials. Kir
channels in healthy glial cells seem to be ﬁtted very well for
this task, as they have a large open probability at resting
potential. This means that at resting potential, a relatively
high number of Kir channels are open. In addition, with
increasing extracellular [K+] their conductance increases
as well, which makes them perfectly suited for the task
of correcting an excess of K+ in the extracellular space
[22]. Mislocalization of Kir channels in glioblastoma cells
(Figure 1) renders these cells insuﬃcient for these tasks,
resulting in accumulation of K+ in the extracellular space.
This accumulation occurs in concurrence with epileptic
seizures [25], although the underlying mechanism is not
entirely clear. Peritumoral epileptic seizures are often seen in
glioblastoma patients, perhaps facilitated by mislocalization
of Kir channels. On the other hand, it is likely that very
few to no neurons survive around glioblastoma cells due to
their invasive behavior. Moreover, increased concentrations
of glutamate in gliomas have been reported [26]. These
arguments, supported by the excitotoxic properties of high
glutamate concentrations to neurons, render high glutamate
release a more logical suspect of causing epileptical seizures
than high [K+] in the extracellular space.
On the other hand, mislocalized Kir channels can con-
tribute indirectly to epileptic seizures as they fail in their
function of establishing a very negative resting potential. At
the depolarized resting potentials of −20 to −40mV that
characterize glioma cells [21], the Na+ gradient across the
plasma membrane is diminished. As a consequence, Na+-
dependent glutamate transporters become inactive, increas-
ing the extracellular glutamate concentration and thereby
possibly causing epileptic seizures [23].
2.1.3. Ether ` AG o - G oK + Channels. Other candidate channels
possibly responsible for the depolarized resting membrane
potential in glioblastoma cells are the ether ` ag o - g o1( E A G 1 )
and ether ` a go-go related 1 (ERG1) channels. Expression of
these channels is upregulated in glioblastoma. Depolarized
resting membrane potential allows large hyperpolarizations,
which provide a driving force for Ca2+ entry. Ca2+ is neces-
sary for cell-cycle progression. In this way, EAG1 and ERG1
channels can contribute to gliomagenesis.
Several studies have described expression levels of hEAG1
and hERG1 in glioblastoma, which encodes EAG1 and ERG1
channels,respectively.However,theresultsarecontradictory.
Patt et al. reported low expression of hEAG1 and hERG1 in
5 glioblastoma samples compared to healthy brain tissue.
Expression was elevated in low-grade gliomas [27]. This
contradicts with the hypothesis above. In contrast, Masi
et al. found elevated expression of hERG1 in 26 glioblastoma
samples, supporting the hypothesis above [28]. The observa-
tion by Masi et al. is supported by other literature, reporting
increased ERG1 mRNA expression, elevated protein levels
and high densities of ERG1 channels in other tumors, such
as colorectal cancer [29], endometrial adenocarcinoma [30],
and myeloid leukemia [31].
ERG1 activity has also been reported to be correlated
with induction of vascular endothelial growth factor (VEGF)
secretion,therebycontributingtoangiogenesis[28].Primary
glioblastomasarecharacterizedbyextensiveneoangiogenesis
[32].
2.2. Chloride Channels
2.2.1. ClC Family Channels. Besides the gBK channel dis-
cussed earlier, the ClC-3 chloride channel is another impor-
tant candidate channel to facilitate migrating behavior
of glioblastoma cells [10]. ClC-3 channel expression was,
together with that of ClC-2 and ClC-5, indeed high in
glioblastoma cell lines and biopsy tissue compared to healthy4 ISRN Neurology
glialcells.Wholecellpatch-clamprecordingsincombination
with channel-speciﬁc antisense oligonucleotides showed that
ClC-3 channels facilitated outwardly rectifying current. On
theotherhand,ClC-2channelsfacilitatedinwardlyrectifying
currents [33]. As a result of the relative overexpression of
ClC-3 as compared to ClC-2 [33], the outwardly rectifying
current may prevail over the inwardly rectifying current. As
a consequence the glioblastoma cell depolarizes, which is
needed to pass the G2/M checkpoint in the cell cycle [6].
In addition, the overexpression of both channels equips
glioblastoma cells with an improved ability to transport Cl−.
This may facilitate rapid changes in cell size and shape as
glioblastoma cells invade through sinuous extracellular brain
spaces [33].
Inhibition of ClC-3 channels using chlorotoxin indeed
markedly but not completely inhibited glioblastoma cell
invasion in vitro. The same eﬀect was accomplished using
ClC-3 siRNA knockdown. In addition, the nonspeciﬁc
ClC-blocker 5-nitro-2-(3-phenylpropylamino) benzoic acid
(NPPB) completely inhibited glioblastoma cell invasion [9].
Limitations of this study include the possibility that the
glioblastoma cell was overdosed with NPPB and invasion
was stopped by cytotoxic levels of NPPB. It is unclear
whether concentrations of NPPB were just suﬃcient to block
ClC channels. This doubt was also raised in studies where
gBK channel inhibition correlated with proliferation [19].
Secondly,NPPBhasalsobeenreportedtobeaCa2+-activated
K+-channel inhibitor [34]. This fact may compromise the
implication of ClC-3 in glioblastoma cell invasion.
ClC-3isregulatedthroughphosphorylationviaCa2+/cal-
modulin-dependent protein kinase II (CaMKII). CaMKII
was infused intracellularly to D54 glioblastoma cells via a
patch-clamp pipette, increasing Cl− currents 3-fold. In addi-
tion, administration of autocamtide-2, a CaMKII-specific
inhibitor, inhibited this current. To conﬁrm the relation
between ClC-3 and CaMKII, ClC-3 was shown to be
knocked down after CaMKII modulation of Cl− currents
was lost. Furthermore, immunohistochemistry colocalized
ClC-3 with CaMKII. Interestingly, inhibition of CaMKII in
ClC-3-expressing cells reduced glioblastoma cell invasion to
the same extent as direct inhibition of ClC-3 [35]. These
ﬁndings suggest that CaMKII is a molecular link between
intracellular[Ca2+]changesandClC-3conductancerequired
for cell movement during invasive migration in glioblas-
toma.
2.3. Calcium Channels. Ca2+ is required by glioblastoma
c e l l sa sas e c o n dm e s s e n g e rt os u p p o r tc e l lm i g r a t i o n .
Oscillatory changes in intracellular [Ca2+] that correlate
with cell invasion and migration have been observed. It has
been hypothesized that these changes in intracellular [Ca2+]
activate ClC-3 channels through CaMKII. This in turn may
initiate glioblastoma invasion [35, 36].
Glioblastoma cells express Ca2+ permeable alpha-amino-
3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) gluta-
mate receptors (Figure 1). These glutamate receptors have
become Ca2+ permeable due to the lack of the GluR2 subunit
as they have been assembled entirely of GluR1 and/or GluR4
subunits. AMPA receptors containing GluR2 subunits show
little Ca2+ permeability, while those lacking GluR2 subunits
exhibit high Ca2+ permeability due to a deformed pore
with an aberrant size and polarity. Adenovirus-mediated
transfer of the GluR2 cDNA decreased intracellular [Ca2+],
inhibited cell migration and induced apoptosis. However,
overexpression of Ca2+ pe rmeab leAMP Ar ec ept o r sincr eased
migration and proliferation of glioblastoma cells in vitro.
GluR2 was indeed not expressed in most glioblastoma
surgical samples. These ﬁndings implicate Ca2+-permeable
AMPA receptors in proliferation, migration and invasion of
glioblastoma [8]. It can be hypothesized that this is due
to increased intracellular [Ca2+], which in turn facilitates
increased activity of gBK and ClC-3 channels.
The same theory applies to a study in which inhibition of
IP3Rs u b t y p e3( I P 3R3) was achieved using caﬀeine. Inhibi-
tion of IP3R3 led to decreased intracellular [Ca2+]. This was
associated with inhibited migration of glioblastoma cells in
vitro. In addition, an increase of mean survival was observed
after caﬀeine was administered to a mouse xenograft model
of glioblastoma. These mice had a 6μg/mL serum caﬀeine
concentration. This is approximately the same concentration
in people that drink two to ﬁve cups of coﬀee a day. These
ﬁndingssuggestthatIP3R3canserveasapossibletherapeutic
target [13]. It would be interesting to investigate whether
large cohort studies can associate coﬀee consumption with
a lower incidence of glioblastoma or prolonged survival.
However, such information is not available yet. With a yearly
glioblastoma incidence of 3.5 per 100,000 people, study sizes
areprobablynotlargeenoughtoshowsuchresults.Theeﬀect
of caﬀeine on the survival of glioblastoma mouse models is
interesting as caﬀeine is regarded as “not classiﬁable as to
its carcinogenicity to humans” by the WHO, meaning that
there is contradictory evidence about its carcinogenic hazard
[37].
The Ca2+-permeable transient receptor potential canon-
ical channel protein 6 (TRPC6) has been implicated in
glioma proliferation. TRPC6 is overexpressed in human
glioma cells, and inhibition suppressed intracellular [Ca2+]
and cell growth and induced cell cycle arrest at the G2/M
phase. In mouse models with xenografted human tumors,
inhibition of TRPC6 reduced tumor volume and increased
mean survival [38].
2.4. Sodium Channels. In contrast to mutations found in
potassium and calcium ion channels, sodium channel muta-
tions correlated with shorter survival in a univariate analysis
[39]. The authors reported that all samples with IDH1
mutations did not have any sodium channel mutations.
However, this association was not signiﬁcant. This may be
due to the small sample size of the study (21 patients).
IDH1 encodes for an enzyme that functions at a
crossroads of cellular metabolism. Mutations in IDH1 have
been identiﬁed to be associated with a speciﬁc subgroup of
glioblastoma patients who are younger and have a prolonged
survival [4, 40]. After correction for IDH1, the diﬀerence
in survival between patients with mutated and unmutated
sodium channels dropped to nonsigniﬁcant levels. Further
research is needed to investigate the association between
mutations in IDH1 and sodium channels and whether theISRN Neurology 5
eﬀect of sodium channel mutations on survival is indepen-
dent of IDH1 mutation status.
Furthermore, among the patients with mutations in
sodium channels, the mutations were scattered over the
diﬀerent genes. All 14 sodium channel genes were mutated
only once among the 21 patients except for SCN9A,w h i c h
was mutated twice. In addition, of the 12 patients with
sodium channel mutations, only 2 had mutations in more
than one gene [39]. This could suggest a similar function,
and therefore mutual exclusivity among these mutations.
This is supported by the fact that of the 14 studied genes,
12 genes were from the SCN or SLC subset classes with 5 and
7 genes, respectively. A similar scattering among the studied
genes and clustering in gene families was observed in
potassium and calcium channel mutation analyses [39].
Moreover, the eﬀect of sodium channel inhibitors on
glioblastoma cell growth was studied. Digoxin and ouabain
were administered to 2 glioblastoma cell lines in vitro.B o t h
drugsshowedantiproliferativeeﬀectsandtoxicityagainstthe
cell lines. Furthermore, cells treated showed an apoptotic
phenotype under the light microscope [39]. These ﬁndings
are supported by the fact that the antiproliferative eﬀect in
cancer of cardiac glycosides is well known [41, 42]. Fur-
thermore, they may be neuroprotective [43]. The underlying
mechanism of these side eﬀects has not been clariﬁed yet,
although inhibition of sodium channels in brain tissue could
be the cause of this.
Another study observed an inward, amiloride-sensitive
Na+ current in glioblastoma cell lines and tumor samples.
These currents were not observed in normal astrocytes or
low-grade astrocytomas. Currently, brain Na+ channels
(BNaCs) are the only amiloride-sensitive Na+ channels iden-
tiﬁed in the brain. PCR analyses indeed demonstrated the
presence of BNaC mRNA in these tumors [44].
Finally, the eﬀect of Psalmotoxin 1, an inhibitor of
cation currents mediated by acid-sensing ion channels, was
studied using the whole-cell patch-clamp technique. This
toxin inhibited Na+ currents in glioblastoma cell lines and
human glioblastoma samples, but not in normal human
astrocytes [45]. Since this eﬀect can only be measured using
electrophysiological experiments, the diagnostic value seems
low. However, if the Na+ current facilitated by acid-sensing
ion channels proves essential for glioblastoma cells in vivo,
inhibition of Psalmotoxin may serve as a possible future
therapy.
3. FutureTherapeutic Targets
3.1. Ion Channels. Given the important role that gBK and
ClC-3 channels are thought to have in glioma invasion
and migration, these channels may render a promising
therapeutic target to render glioblastoma less aggressive.
However, even if in vivo inhibition of gBK and ClC-3
channels can inhibit glioblastoma invasion and migration,
these future therapies probably have to be administered at
an early stage in order to make a diﬀerence in the treatability
by resection and radiotherapy.
Takenthecentralroleofintracellular[Ca2+]inClC-3and
gBK channel activity into account, inﬂuencing glioblastoma
Ca2+ homeostasis may be a target of future therapies. This
canbe accomplishedbyinhibition ofCa2+-permeableAMPA
receptors, for example by adenovirus-mediated transfer of
GluR2 cDNA [8]. Another possible therapy is inhibition of
IP3R3 using caﬀeine [13]. However, the carcinogenic hazard
of caﬀeine is not clear yet [37]. On the other hand, Ca2+
coupling to ClC-3 and gBK channels can be disturbed by
inhibiting CaMKII [35] or lipid rafts, [20]r e s p e c t i v e l y .I n
addition, inhibition of TRPC6 has shown promising results
both in vitro and in vivo in mouse models.
The ﬁnding that glioma cells’ depolarized resting mem-
brane potential and their inability to maintain K+,N a + and
glutamate homeostasis are caused by mislocalization of Kir
channels suggests that these channels function at a cross-
roads of cellular homeostasis and basic electrophysiological
functions in glioma cells [23]. Correction of this mislocal-
ization could therefore serve as a possible therapeutic target.
However, the underlying mechanism of this mislocalization
is currently unknown, making therapy uncertain in the near
future.
Recently, the antiproliferative eﬀect of cardiac glycosides
on glioblastoma cell growth in vitro was studied. Digoxin
and ouabain proved useful inhibitors of cell proliferation
[39]. However, concentrations that provide an anticancer
eﬀect are high and induce severe cardiovascular side eﬀects.
Therefore, their development as anticancer agents has been
limited thus far. Chemical modiﬁcation is needed to increase
aﬃnity for tumor sodium channels and decrease aﬃnity for
cardiac sodium channels [42].
3.2. Chemotherapeutic Agents. Tetrandrine is an inhibitor of
gBK channels. It therefore may inhibit the extensive invasion
of glioblastoma cells. Moreover, tetrandrine has cytotoxic
eﬀects. Furthermore, it exacerbates radiation-induced cell-
cycleperturbation,therebyinducingapoptosisandradiosen-
sitization in glioblastoma cells. In addition, it has antiangio-
genic eﬀects. These capabilities render it a possible useful
therapy to treat glioblastomas, especially combined with
radiotherapy or other chemotherapeutic agents [46]. The
combination of classical cytotoxic, apoptotic, radiosensiti-
zation and antiangiogenic eﬀects with inhibition of gBK
channels is promising. However, the eﬀect of tetrandrine
has thus far only been studied in rats [47]. Furthermore,
tetrandrines’ large arsenal of possible therapeutic targets in
gliomas may impede to ﬁnd an optimal dosage.
The blood-brain tumor barrier is an important hurdle
to overcome in glioblastoma treatment. Temozolomide, a
chemotherapeutic agent that was discussed earlier, is cur-
rently, together with radiotherapy, the golden standard in
glioblastoma treatment. However, temozolomide crosses the
blood-brain tumor barrier insuﬃciently to have a signif-
icant impact on patient survival. The same accounts for
trastuzumab, which may be especially eﬀective in a distinct
glioblastoma subgroup (neural, as discussed by Verhaak
et al. [48]) when combined with temozolomide. Therefore,
both drugs were coinfused with minoxidil sulfate, an ATP-
sensitive potassium channel (KATP) activator. In mice, this
indeed resulted in improved selective drug delivery to
glioblastoma. The underlying mechanism is not completely6 ISRN Neurology
understood, but it involves formation of brain vascular
endothelialtranscytoticvesiclestofacilitateabsorptionofthe
drug [49].
3.3. Limitations of Cell Lines. Currently, most research in
the ﬁeld of ion channels in glioma is conducted on glioma
cell lines. However, several experiments have shown that
established glioblastoma cell lines resemble glioblastomas in
patients very poorly when compared at the level of DNA
alterations or gene expression proﬁles [50]. With this in
mind, results from experiments conducted with cell lines
should always be put into the right context. In vitro studies
in human glioblastoma samples or in vivo studies in animal
xenograft models remain needed.
4. Conclusion
At this moment, we have increased our understanding of the
molecular mechanisms involving ion channels underlying
the invasive migration of glioblastoma. However, in contrast
to many other forms of cancer and considering the genetic
research in glioblastoma, consequences for treatment are
lagging behind. Under the shadow of the large and extensive
research on genetic alterations and its eﬀects on therapy
responses in glioblastoma [51], it is doubtful whether any
therapies involving ion channels will ever see the light. Our
current understanding of ion channels in glioblastoma will
most probably lead to drugs that can be given concomitantly
with chemotherapeutic agents to increase their eﬀectivity,
such as the discussed coinfusion with minoxidil sulfate.
In addition, the current knowledge of the involvement
of BK channels, ClC-3 channels and intracellular [Ca2+]
homeostasis in glioblastoma invasion and migration would
justify the ﬁrst steps in drug development targeting these
aspects.
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